X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (368) 368
index medicus (248) 248
female (144) 144
male (144) 144
oncology (136) 136
cancer (123) 123
animals (114) 114
adult (105) 105
clinical neurology (101) 101
tumors (97) 97
middle aged (93) 93
brain neoplasms - pathology (87) 87
pathology (77) 77
aged (68) 68
cell line, tumor (67) 67
neurosciences (63) 63
chemotherapy (62) 62
mice (58) 58
analysis (56) 56
glioma - pathology (55) 55
gliomas (55) 55
prognosis (55) 55
research (55) 55
glioma (54) 54
surgery (52) 52
cell biology (51) 51
immunohistochemistry (50) 50
apoptosis (49) 49
brain neoplasms - genetics (49) 49
oligodendroglioma (49) 49
expression (47) 47
medicine & public health (46) 46
proteins (46) 46
gene expression (45) 45
adolescent (43) 43
mixed function oxygenases - genetics (43) 43
biochemistry & molecular biology (41) 41
child (41) 41
pharmacology & pharmacy (40) 40
lymphocyte culture test, mixed (39) 39
magnetic resonance imaging (39) 39
mixed function oxygenases - metabolism (39) 39
survival (39) 39
genetic aspects (37) 37
mixed oligoastrocytomas (37) 37
rats (37) 37
dna methylation (36) 36
mixed glioma (35) 35
article (34) 34
care and treatment (33) 33
medicine (33) 33
astrocytoma - pathology (32) 32
brain (32) 32
mutation (32) 32
brain neoplasms - therapy (31) 31
differentiation (31) 31
glioblastoma (31) 31
glioma - genetics (31) 31
proto-oncogene proteins - genetics (31) 31
diagnosis (30) 30
astrocytoma (29) 29
brain neoplasms - surgery (28) 28
brain tumors (28) 28
methylation (28) 28
nanoparticles (28) 28
proto-oncogene proteins - metabolism (28) 28
astrocytomas (27) 27
radiotherapy (27) 27
glioblastoma-multiforme (26) 26
mixed gliomas (26) 26
mixed micelles (26) 26
brain neoplasms - diagnosis (25) 25
comparative genomic hybridization (25) 25
gene expression regulation, neoplastic (25) 25
health aspects (25) 25
multidisciplinary sciences (25) 25
oligodendroglioma - pathology (25) 25
tumor (25) 25
brain neoplasms - metabolism (24) 24
survival analysis (24) 24
cell proliferation (23) 23
drug delivery systems (23) 23
medicine, research & experimental (23) 23
cells, cultured (22) 22
development and progression (22) 22
gene (22) 22
hematology (22) 22
in-vitro (22) 22
kinases (22) 22
nanoscience & nanotechnology (22) 22
oligodendroglioma - genetics (22) 22
young adult (22) 22
aged, 80 and over (21) 21
biology (21) 21
cytotoxicity (21) 21
dna-binding proteins - genetics (21) 21
epigenetics (21) 21
glioblastoma - pathology (21) 21
immunology (21) 21
metastasis (21) 21
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Cancer Letters, ISSN 0304-3835, 12/2019, Volume 467, pp. 58 - 71
Chromatinolysis refers to enzymatic degradation of nuclear DNA and is regarded as one of the crucial events leading to cell death. Mixed-lineage kinase... 
MLKL | Glioma | Necroptosis | Shikonin | Chromatinolysis | APOPTOSIS | DOMAIN-LIKE PROTEIN | MIXED LINEAGE KINASE | CANCER | NUCLEAR TRANSLOCATION | RIP3 CONTRIBUTE | NECROSIS | ONCOLOGY | INCREASE | CHROMOSOMAL DNA FRAGMENTATION | AIF
Journal Article
中国药理学报:英文版, ISSN 1671-4083, 2017, Volume 38, Issue 11, pp. 1543 - 1553
Journal Article
American Journal of Pathology, The, ISSN 0002-9440, 2012, Volume 181, Issue 2, pp. 675 - 683
Journal Article
Neurology, ISSN 0028-3878, 04/2000, Volume 54, Issue 7, pp. 1442 - 1448
Background: Low-grade oligodendrogliomas and mixed gliomas can be indolent and remain unchanged for years. Optimal timing and effectiveness of initial... 
Mixed glioma | Chemotherapy | Radiation therapy | Outcome | Oligodendroglioma | PROGNOSTIC FACTORS | SURVIVAL | oligodendroglioma | mixed glioma | SUCCESSFUL CHEMOTHERAPY | ADULTS | PCV CHEMOTHERAPY | chemotherapy | CLINICAL NEUROLOGY | RADIATION-THERAPY | BRAIN-TUMORS | radiation therapy | POSTOPERATIVE IRRADIATION | AGGRESSIVE OLIGODENDROGLIOMA | outcome | CEREBRAL OLIGODENDROGLIOMA | Follow-Up Studies | Glioma - diagnosis | Humans | Middle Aged | Oligodendroglioma - diagnosis | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Cyclophosphamide - therapeutic use | Neoplasms, Second Primary - therapy | Radiotherapy, Adjuvant - adverse effects | Vindesine - adverse effects | Glioma - therapy | Vindesine - therapeutic use | Adult | Female | Retrospective Studies | Brain Neoplasms - mortality | Postoperative Complications | Oligodendroglioma - mortality | Glioma - mortality | Brain Neoplasms - diagnosis | Neoplasm Recurrence, Local - therapy | Survival Rate | Treatment Outcome | Neoplasm Recurrence, Local - diagnosis | Neoplasms, Second Primary - diagnosis | Disease-Free Survival | Oligodendroglioma - therapy | Cisplatin - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Brain Neoplasms - therapy | Cisplatin - adverse effects
Journal Article
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 3/2014, Volume 117, Issue 1, pp. 183 - 189
Journal Article
1983, ISBN 9780890049969, xi, 224
Book
by Kim, JH and Jang, WY and Jung, TY and Jung, S and Kim, KK and Kim, HS and Kim, EH and Lee, MC and Moon, KS and Lee, KH
FRONTIERS IN ONCOLOGY, ISSN 2234-943X, 08/2019, Volume 9, p. 828
Following the introduction of the molecular classification of gliomas by the WHO in 2016, molecularly-proven lineage conversion during glioma recurrence has... 
OLIGOASTROCYTOMA | mixed oligoastrocytoma | 1p/19q-codeletion | ATRX | GENOMIC ANALYSIS | CLASSIFICATION | recurrent glioma | genetic heterogeneity | HETEROGENEITY | GLIOBLASTOMA | EVOLUTION | clonal evolution | ONCOLOGY | cell lineage | MUTATIONS | REVEALS | Usage | Genetic aspects | Nucleotide sequencing | Research | Diagnosis | Gene expression | Astrocytoma | Risk factors | DNA sequencing
Journal Article